Los Angeles Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $710K | Buy |
|
|||||
|
2025
Q2 | $222K | Sell |
|
|||||
|
2025
Q1 | $991K | Sell |
|
|||||
|
2024
Q4 | $1.1M | Sell |
|
|||||
|
2024
Q3 | $2.5M | Buy |
|
|||||
|
2024
Q2 | $1.48M | Sell |
|
|||||
|
2024
Q1 | $2.76M | Sell |
|
|||||
|
2023
Q4 | $2.58M | Buy |
|
|||||
|
2023
Q3 | $2.53M | Sell |
|
|||||
|
2023
Q2 | $2.26M | Buy |
|
|||||
|
2023
Q1 | $1.22M | Sell |
|
|||||
|
2022
Q4 | $1.76M | Sell |
|
|||||
|
2022
Q3 | $1.58M | Buy |
|
|||||
|
2022
Q2 | $635K | Buy |
|
|||||
|
2022
Q1 | $649K | Buy |
|
|||||
|
2021
Q4 | $706K | Buy |
|
|||||
|
2021
Q3 | $365K | Sell |
|
|||||
|
2021
Q2 | $638K | Buy |
|
|||||
|
2021
Q1 | $413K | Sell |
|
|||||
|
2020
Q4 | $497K | Buy |
|
|||||
|
2020
Q3 | $406K | Buy |
|
|||||
|
2020
Q2 | $570K | Buy |
|
|||||
|
2020
Q1 | $278K | Buy |
|
|||||
|
2019
Q4 | $144K | Buy |
|